Kyorin Pharmaceutical announces a sales rights transfer agreement for anti-bacterial agent with GaldermaK.K
March 19, 2002
Sales rights transfer agreement in Japan for the anti-bacterial agent PEKIRON® Cream
Kyorin Pharmaceutical Co., Ltd. (President, Ikuo Ogihara, Head office: Chiyoda-ku, Tokyo) announces a sales rights transfer agreeme nt in Japan for the Morpholine derivatives anti-bacterial agent, PEKIRON® Cream (amorolfine,INN) with Galderma K.K (an incorporated Japanese company and a subsidiary of the joint venture between Neslé and L'Oréal. General manager, Eiichi Kitano, Japan office: Chiyoda-ku, Tokyo).
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.